149 related articles for article (PubMed ID: 8861661)
1. Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity.
Ducharme J; Abdullah S; Wainer IW
J Chromatogr B Biomed Appl; 1996 Mar; 678(1):113-28. PubMed ID: 8861661
[TBL] [Abstract][Full Text] [Related]
2. Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity.
Kashuba AD; Nafziger AN; Kearns GL; Leeder JS; Gotschall R; Gaedigk A; Bertino JS
Pharmacogenetics; 1999 Aug; 9(4):453-62. PubMed ID: 10780265
[TBL] [Abstract][Full Text] [Related]
3. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.
Di Marco MP; Edwards DJ; Wainer IW; Ducharme MP
Life Sci; 2002 Jul; 71(10):1149-60. PubMed ID: 12095536
[TBL] [Abstract][Full Text] [Related]
4. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation.
Jones DR; Gorski JC; Haehner BD; O'Mara EM; Hall SD
Clin Pharmacol Ther; 1996 Oct; 60(4):374-84. PubMed ID: 8873685
[TBL] [Abstract][Full Text] [Related]
5. Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?
Yu A; Haining RL
Drug Metab Dispos; 2001 Nov; 29(11):1514-20. PubMed ID: 11602530
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatography assay for simultaneous determination of dextromethorphan and its main metabolites in urine and in microsomal preparations.
Bendriss EK; Markoglou N; Wainer IW
J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):209-15. PubMed ID: 11318417
[TBL] [Abstract][Full Text] [Related]
7. A urine metabolic ratio of dextromethorphan and 3-methoxymorphinan as a probe for CYP3A activity and prediction of cyclosporine clearance in healthy volunteers.
Min DI; Ku YM; Vichiendilokkul A; Fleckenstein LL
Pharmacotherapy; 1999 Jun; 19(6):753-9. PubMed ID: 10391422
[TBL] [Abstract][Full Text] [Related]
8. Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan.
McCune JS; Lindley C; Decker JL; Williamson KM; Meadowcroft AM; Graff D; Sawyer WT; Blough DK; Pieper JA
J Clin Pharmacol; 2001 Jul; 41(7):723-31. PubMed ID: 11452704
[TBL] [Abstract][Full Text] [Related]
9. Intra-individual variability and influence of urine collection period on dextromethorphan metabolic ratios in healthy subjects.
Chládek J; Zimová G; Martínková J; Tůma I
Fundam Clin Pharmacol; 1999; 13(4):508-15. PubMed ID: 10456294
[TBL] [Abstract][Full Text] [Related]
10. Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity.
Jones DR; Gorski JC; Hamman MA; Hall SD
J Chromatogr B Biomed Appl; 1996 Mar; 678(1):105-11. PubMed ID: 8861660
[TBL] [Abstract][Full Text] [Related]
11. A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.
Vengurlekar SS; Heitkamp J; McCush F; Velagaleti PR; Brisson JH; Bramer SL
J Pharm Biomed Anal; 2002 Aug; 30(1):113-24. PubMed ID: 12151071
[TBL] [Abstract][Full Text] [Related]
12. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans.
Jacqz-Aigrain E; Funck-Brentano C; Cresteil T
Pharmacogenetics; 1993 Aug; 3(4):197-204. PubMed ID: 8220439
[TBL] [Abstract][Full Text] [Related]
13. Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A.
von Moltke LL; Greenblatt DJ; Grassi JM; Granda BW; Venkatakrishnan K; Schmider J; Harmatz JS; Shader RI
J Pharm Pharmacol; 1998 Sep; 50(9):997-1004. PubMed ID: 9811160
[TBL] [Abstract][Full Text] [Related]
14. Effect of black seed on dextromethorphan O- and N-demethylation in human liver microsomes and healthy human subjects.
Al-Jenoobi FI; Al-Thukair AA; Abbas FA; Ansari MJ; Alkharfy KM; Al-Mohizea AM; Al-Suwayeh SA; Jamil S
Drug Metab Lett; 2010 Jan; 4(1):51-5. PubMed ID: 20201775
[TBL] [Abstract][Full Text] [Related]
15. A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study.
Spanakis M; Vizirianakis IS; Mironidou-Tzouveleki M; Niopas I
Biomed Chromatogr; 2009 Nov; 23(11):1131-7. PubMed ID: 19444798
[TBL] [Abstract][Full Text] [Related]
16. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
17. In-vivo indices of CYP2D6 activity: comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasma.
Chládek J; Zimová G; Beránek M; Martínková J
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):651-7. PubMed ID: 11214771
[TBL] [Abstract][Full Text] [Related]
18. Validation of a liquid chromatography-mass spectrometry method to assess the metabolism of dextromethorphan in rat everted gut sacs.
Arellano C; Philibert C; Dane à Yakan EN; Vachoux C; Lacombe O; Woodley J; Houin G
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):105-13. PubMed ID: 15797528
[TBL] [Abstract][Full Text] [Related]
19. Single-point plasma or urine dextromethorphan method for determining CYP3A activity.
Kuo BP; Hu OY; Hsiong CH; Pao LH; Chen TS; Hung CF
Biopharm Drug Dispos; 2003 Dec; 24(9):367-73. PubMed ID: 14689465
[TBL] [Abstract][Full Text] [Related]
20. Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping.
Hoskins JM; Shenfield GM; Gross AS
J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):81-7. PubMed ID: 9300912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]